세계의 응고 검사 시장 규모 조사 : 제품 유형별, 검사 유형별, 최종 사용자별, 지역별 예측(2022-2032년)

Global Coagulation Testing Market is valued at approximately USD 3.44 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.07% over the forecast period 2024-2032. Coagulation, or clotting, is a critical physiological process in which blood transforms into a thickened mass to prevent excessive bleeding. This complex mechanism hinges on a delicate balance between procoagulants and anticoagulants. It helps assess the functionality of various components in the blood clotting process, which is essential for stopping bleeding and preventing excessive hemorrhage. These tests are used to diagnose and monitor various conditions, including bleeding disorders clotting disorders and to manage anticoagulant therapy. Accurate coagulation testing is essential for effective treatment and prevention of complications related to abnormal bleeding or clotting.

The Global Coagulation Testing Market is driven by increasing prevalence of liver diseases globally has significantly bolstered the demand for coagulation testing. Accurate and timely coagulation tests are imperative for diagnosing and managing various liver conditions, thereby enhancing patient outcomes. Additionally, continuous research and development activities focused on creating innovative and more precise coagulation tests are further accelerating market growth. The introduction of point-of-care coagulation testing devices has revolutionized patient care by offering rapid and reliable results, which are crucial for managing critical conditions in real-time. Moreover, rising focus on personalized medicine and the need for accurate diagnostic tools is anticipated to create lucrative opportunities for the market. However, the market faces challenges such as the shortage of skilled professionals capable of conducting and interpreting coagulation tests is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the coagulation testing market attributed to its high prevalence of lifestyle disorders, advanced healthcare infrastructure, and favorable reimbursement policies. The presence of major market players and continuous technological advancements further bolster the region's market position. Furthermore, the Asia-Pacific region is anticipated to exhibit the highest growth rate during the forecast period, driven by improving healthcare infrastructure, increasing awareness about coagulation disorders, and a growing aging population.

Major market players included in this report are:

• F. Hoffmann-La Roche Ltd.
• Abbott
• Siemens Healthineers
• Sysmex Corporation
• Universal Biosensors, Inc.
• HemoSonics, LLC
• Thermo Fisher Scientific Inc.
• Randox Laboratories Ltd.
• Horiba, Ltd.
• Agappe Diagnostics Ltd.
• Medtronic
• Helena Laboratories, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product Type:

• Instruments
• Consumables

By Test Type:

• Prothrombin Time (PT)
• Activated Partial Thromboplastin Clotting Time (APTT)
• Thrombin Time (TT)
• Activated Clotting Time (ACT)
• Others

By End-user:

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Coagulation Testing Market Executive Summary

• 1.1. Global Coagulation Testing Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product Type
  • 1.3.2. By Test Type
  • 1.3.3. By End-user
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Coagulation Testing Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Coagulation Testing Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rise in Prevalence of Liver Diseases
  • 3.1.2. R&D of New Tests
• 3.2. Market Challenges
  • 3.2.1. Lack of Skilled Professionals
  • 3.2.2. Pressure on Histology Laboratories
• 3.3. Market Opportunities
  • 3.3.1. Focus on Personalized Medicine
  • 3.3.2. Advancements in Diagnostic Technologies

Chapter 4. Global Coagulation Testing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Coagulation Testing Market Size & Forecasts by Product Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Coagulation Testing Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Instruments
  • 5.2.2. Consumables

Chapter 6. Global Coagulation Testing Market Size & Forecasts by Test Type 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Coagulation Testing Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Prothrombin Time (PT)
  • 6.2.2. Activated Partial Thromboplastin Clotting Time (APTT)
  • 6.2.3. Thrombin Time (TT)
  • 6.2.4. Activated Clotting Time (ACT)
  • 6.2.5. Others

Chapter 7. Global Coagulation Testing Market Size & Forecasts by End-user 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Coagulation Testing Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Hospitals and Clinics
  • 7.2.2. Diagnostic Laboratories
  • 7.2.3. Home Care Settings
  • 7.2.4. Others

Chapter 8. Global Coagulation Testing Market Size & Forecasts by Region 2022-2032

• 8.1. North America Coagulation Testing Market
  • 8.1.1. U.S. Coagulation Testing Market
    • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Test Type breakdown size & forecasts, 2022-2032
    • 8.1.1.3. End-user breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Coagulation Testing Market
    • 8.1.2.1. Product Type breakdown size & forecasts, 2022-2032
    • 8.1.2.2. Test Type breakdown size & forecasts, 2022-2032
    • 8.1.2.3. End-user breakdown size & forecasts, 2022-2032
• 8.2. Europe Coagulation Testing Market
  • 8.2.1. U.K. Coagulation Testing Market
  • 8.2.2. Germany Coagulation Testing Market
  • 8.2.3. France Coagulation Testing Market
  • 8.2.4. Spain Coagulation Testing Market
  • 8.2.5. Italy Coagulation Testing Market
  • 8.2.6. Rest of Europe Coagulation Testing Market
• 8.3. Asia-Pacific Coagulation Testing Market
  • 8.3.1. China Coagulation Testing Market
  • 8.3.2. India Coagulation Testing Market
  • 8.3.3. Japan Coagulation Testing Market
  • 8.3.4. Australia Coagulation Testing Market
  • 8.3.5. South Korea Coagulation Testing Market
  • 8.3.6. Rest of Asia Pacific Coagulation Testing Market
• 8.4. Latin America Coagulation Testing Market
  • 8.4.1. Brazil Coagulation Testing Market
  • 8.4.2. Mexico Coagulation Testing Market
  • 8.4.3. Rest of Latin America Coagulation Testing Market
• 8.5. Middle East & Africa Coagulation Testing Market
  • 8.5.1. Saudi Arabia Coagulation Testing Market
  • 8.5.2. South Africa Coagulation Testing Market
  • 8.5.3. Rest of Middle East & Africa Coagulation Testing Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. F. Hoffmann-La Roche Ltd.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Abbott
  • 9.3.3. Siemens Healthineers
  • 9.3.4. Sysmex Corporation
  • 9.3.5. Universal Biosensors, Inc.
  • 9.3.6. HemoSonics, LLC
  • 9.3.7. Thermo Fisher Scientific Inc.
  • 9.3.8. Randox Laboratories Ltd.
  • 9.3.9. Horiba, Ltd.
  • 9.3.10. Agappe Diagnostics Ltd.
  • 9.3.11. Medtronic
  • 9.3.12. Helena Laboratories, Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes